Avience Biomedicals Ltd
NSE: AVIENCE
₹349.60
₹-35.75
(-9.28%)
As on 15-Sep-2026IST
Market cap
₹192 Cr
Revenue (TTM)
₹45 Cr
P/E Ratio
21.9
P/B Ratio
7.9
Div. Yield
0 %
Quality Score
8/10
Growth Score
9/10
Valuation Score
8/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹7 Cr
-
ROE
49.9 %
-
ROCE
34.2 %
-
Industry P/E
20.16
-
EV/EBITDA
13.7
-
Debt to Equity
1
-
Book Value
₹56.5
-
EPS
₹17.9
-
Face value
10
-
Shares outstanding
5,485,056
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Avience Biomedicals
| -- | 41.4 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 16.2 | -1.0 | 6.5 | 12.4 | 20.9 | 13.6 | 11.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Avience Biomedicals
|
349.6 | 191.8 | 45.2 | 7.2 | -- | 49.9 | 21.9 | 7.9 |
| 238.0 | 158.7 | 34.2 | -4.8 | -11.3 | -30.5 | -- | 9.0 | |
| 112.0 | 213.3 | 55.1 | 5.1 | -- | 7.7 | 41.8 | 3.1 | |
| 131.3 | 180.6 | 43.1 | 6.6 | -- | 40.6 | 36.6 | 7.9 | |
| 322.2 | 308.1 | 153.1 | 4.3 | 1.4 | 2.3 | 71 | 1.7 | |
| 1,704.6 | 17,268.5 | 1,997.4 | 307.0 | 16.7 | 10.6 | 54.8 | 5.4 | |
| 676.6 | 1,578.4 | 341.7 | 55.7 | -- | 25.6 | 28.3 | 6.2 | |
| 165.8 | 320.7 | 183.3 | 12.7 | 12.7 | 10.4 | 29.5 | -- | |
| 100.2 | 164.6 | 93.7 | 2.4 | 11.7 | 6.2 | 69.5 | 3.4 | |
| 362.0 | 711.9 | 92.4 | 4.7 | -- | 4.9 | 57.9 | 7.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Avience Biomedicals
--
-
Incorporated
2019
-
Chairman
Dharam Deo Choudhary
-
Managing Director
Dharam Deo Choudhary
-
Headquarters
New Delhi, Delhi
-
Website
Looking for more details about Avience Biomedicals Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Avience Biomedicals
What is the current share price of Avience Biomedicals Ltd Today?
The share price of Avience Biomedicals Ltd is ₹349.60 (NSE) as of 15-Sep-2026 IST. Avience Biomedicals Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Avience Biomedicals Ltd?
The P/E ratio of Avience Biomedicals Ltd is 21.91 times as on 15-Sep-2026, a 9 premium to its peers’ median range of 20.16 times.
The P/B ratio of Avience Biomedicals Ltd is 7.91 times as on 15-Sep-2026, a 247 premium to its peers’ median range of 2.28 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2025 |
0.00 |
0.00 |
What is the 52 Week High and Low of Avience Biomedicals Ltd?
The 52-week high and low of Avience Biomedicals Ltd are Rs 414.95 and Rs 222.00 as of 16-Sep-2026.
What is the market cap of Avience Biomedicals Ltd?
Avience Biomedicals Ltd has a market capitalisation of ₹ 192 Cr as on 15-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Avience Biomedicals Ltd?
Before investing in Avience Biomedicals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.